Insider Transactions Reported by 19 Insiders of InMed Pharmaceuticals Inc.

Symbol
INM on Nasdaq
Location
Vancouver, British Columbia, Canada

There are no Buy or Sell transactions made by insiders since 11 Mar 2025

InMed Pharmaceuticals Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bruce Colwill Cfo $10,294 24 Jan 2022
ALEXANDRA DIANE JANET MANCINI Consultant $0 31 Jul 2024
ERIC A. ADAMS President & CEO, Director 19 Dec 2025
MICHAEL WOUDENBERG Chief Operating Officer 19 Dec 2025
Janet P. Grove Director 20 Dec 2024
Brenda Edwards Interim CFO 01 Apr 2022
Netta Jagpal Chief Financial Officer 19 Dec 2025
Catherine Sazdanoff Director 29 Dec 2021
Shane Aaron Johnson Sr VP & General Manager 19 Dec 2025
ANDREW HULL Director 19 Dec 2025
Sarah Li VP Accounting & Controller 16 Dec 2022
Jonathan Tegge Interim CFO 23 Dec 2023
Nicole Lemerond Director 19 Dec 2025
Baldasare Bryan T. Director 20 Dec 2024
William J. Garner Director 24 Jan 2022
Neil A. Klompas Director 19 Dec 2025
Adam D. Cutler Director 24 Jan 2022
John Steven Bathery Director 19 Dec 2025
ERIC C. HSU Sr. VP, Pre-Clinical Res/Dev 19 Dec 2025

Recent Insider Transactions by Companies or Individuals for InMed Pharmaceuticals Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.